CANbridge Pharmaceuticals Inc. had a revenue of 11.12M in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 62.56M, Increased -15.27%. In the fiscal year ending Dec 31, 2024, CANbridge Pharmaceuticals Inc. had annual revenue of 85.10M with -17.27% growth.